Effect of Covid19 on Parkinson’s Disease, Dementia with Lewy Bodies, and Alzheimer’s Disease Study

lewy body dementia illustration


AGE: 40-89 years of age
TYPE: Observational and sample collection
CONDITION: Parkinson’s Disease, Alzheimer’s Disease, dementia with Lewy bodies, progressive supranuclear palsy, corticobasal degeneration

Learn More About This Research Study

This is a research study being conducted at University Hospitals. For more information, please contact Ashley Hawkins, the study coordinator at 216-844-2327 or complete the online form below.

Study Purpose

The purpose of this study is to identify changes on a skin punch biopsy or olfactory mucosa (tissue in the back of the nose) sampling, in which small pieces of skin are removed or a swab or brush is placed in the back of the nose, and then tissue is sent to the laboratory for examination. We are interested in learning how a previous Covid19 infection will affect someone’s neurological condition.

Who Can Participate

Participants between 40-89 years of age with Parksinson’s disease (PD), Alzheimer’s Disease, dementia with Lewy bodies (DLB), progressive palsy (PSP) and corticobasal degeneration or no neurological condition (controls) may be eligible for this study. People who had Covid19 in the past are encouraged to participate in this study.

Request More Information

To learn more about this study, please fill out the form below to request more information.


Study ID

  • STUDY20201499